Radiofrequency Ablation for Lumbar Spondylosis
(LMB-RFA Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, it mentions that participants should have failed conservative treatment, including nonsteroidal anti-inflammatory medications, which might imply that these medications are not effective for you.
What data supports the effectiveness of the treatment Radiofrequency Ablation of Lumbar Medial Branch Nerves for Lumbar Spondylosis?
Research shows that radiofrequency ablation (RFA) of the medial branch nerves can provide pain relief and improve function for 6-12 months, and possibly up to 2 years, in patients with lumbar facet syndrome, which is a similar condition to lumbar spondylosis. About 50% of patients experience long-term improvement, especially those who had pain relief after a preliminary test called a medial branch block.12345
Is radiofrequency ablation for lumbar spondylosis safe?
How is radiofrequency ablation different from other treatments for lumbar spondylosis?
Radiofrequency ablation (RFA) is unique because it uses high-density electrical currents to target and disrupt the nerves that transmit pain signals from the affected facet joints in the spine, providing longer-lasting pain relief compared to other treatments. This procedure is guided by imaging techniques to ensure precise targeting of the nerves, which is not a feature of many other treatments for lumbar spondylosis.278910
What is the purpose of this trial?
The purpose of this voluntary research study is to determine whether the parasagittal approach to lumbar medial branch (LMB) nerve radio frequency ablation (RFA) will have greater efficacy than the traditional approach to lumbar medial branch nerve radio frequency ablation.
Research Team
Yakov Vorobeychik, MD PhD
Principal Investigator
Professor, Department of Anesthesiology
Eligibility Criteria
This trial is for individuals with lumbar spondylosis, a condition affecting the lower back. Participants should be candidates for radiofrequency ablation therapy, which is a treatment to reduce pain by heating nerve tissue. Specific eligibility details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo bilateral radiofrequency ablation (RFA) using both traditional and parasagittal approaches
Follow-up
Participants are monitored for safety and effectiveness after treatment, including self-reported analgesic consumption and pain intensity
Treatment Details
Interventions
- Radiofrequency Ablation of Lumbar Medial Branch Nerves
Find a Clinic Near You
Who Is Running the Clinical Trial?
Milton S. Hershey Medical Center
Lead Sponsor